Blackstone Life Sciences, a private investment company, is making a big bet on its Cambridge neighbor Moderna, the drug firm that has made multiple versions of a vaccine to fend off COVID-19.
The next-gen vaccine also comes in a pre-filled syringe to increase productivity for healthcare workers administering the vaccine. Moderna's approved Covid-19 ... Bancel, CEO of Moderna, said ...
Think it's time for a booster? Moderna says its newest COVID vaccine is showing signs of a stronger immune response against the virus than the current shot being offered and a longer shelf-life.
CEO of Moderna. “mRNA-1283 is a critical component of our combination vaccine against flu and COVID-19, mRNA-1083, and this milestone gives us confidence in our ability to bring this much needed ...
LONDON: Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported ...
mRNA-1283 was found to have a similar safety profile to Moderna's approved ... Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs. Price Action: MRNA shares ...
Moderna, known for its COVID-19 vaccine ... diseases," Moderna CEO Stéphane Bancel said in a release on Wednesday, March 27. As Moderna prepares to unveil its latest vaccine initiatives, the ...
London: Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in line ...
Pfizer Inc. and Moderna Inc. have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price for the Pfizer ...